Preet, GaganAstakala, Rishi VachaspathyRajakulendran, Joy EbenezerOluwabusola, Emmanuel T.Ebel, RainerJaspars, Marcel2023-07-102023-07-102023-07-01Preet, G, Astakala, R V, Rajakulendran, J E, Oluwabusola, E T, Ebel, R & Jaspars, M 2023, '(E)-N-(3-(5-(3-Acetamidopropyl)-3,6-dioxopiperazin-2-yl)propyl)-5-hydroxy-3-methylpent-2-enamide', MolBank, vol. 2023, no. 3, M1680. https://doi.org/10.3390/M16801422-8599ORCID: /0000-0002-7978-7306/work/137948860ORCID: /0000-0003-4034-1873/work/138945098ORCID: /0000-0002-2426-6028/work/163664576ORCID: /0000-0003-3153-4323/work/179747429https://hdl.handle.net/2164/21157Funding The collection of materials was carried out with financial support from the UK Newton Project for UK–Chile Collaboration (JIC CA 586) to Professor Mervyn Bibb, John Inness Centre, Norwich, UK. Acknowledgments The authors would like to thank Albrn Care India, Nidhan Singh Oberoi, and P.S. Oberoi, I.C.A.R-National Dairy Research Institute, India, as well as Aparna Koride for their continued support. They would also like to thank Russell Gray for his support in running the NMR experiments. Data collection was carried out in collaboration with Michael Goodfellow, University of Newcastle, and Juan Asenjo and Barbara Andrews, University of Chile.1340274engdiketopiperazinefungal natural productsAtacama Desertnuclear magnetic resonancesecondary metaboliteHR-ESI-LC-MSQD ChemistrySupplementary DataQDJournal article10.3390/M1680https://doi.org/10.3390/M16803